Billable / Specific Code
ICD-10-CM J70.2 is the diagnosis code for Acute drug-induced interstitial lung disorders. This code falls under the section "Lung diseases due to external agents" within Chapter 10 — Diseases of the respiratory system (J00-J99). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
The following conditions should never be coded at the same time as J70.2. They are mutually exclusive:
Understanding where J70.2 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, J70.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
J70.2 is the ICD-10-CM diagnosis code for "Acute drug-induced interstitial lung disorders". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of J70.2 is J70 ("Respiratory conditions due to other external agents"). J70.2 provides a more specific classification within this category.
J70.2 is located in Section J60-J70 — "Lung diseases due to external agents" within Chapter 10 of the ICD-10-CM Tabular List.
Use J70.2 when the patients documented diagnosis matches "Acute drug-induced interstitial lung disorders" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Acute drug-induced interstitial lung disorders is J70.2.
Yes, J70.2 can be used as a primary diagnosis code since it is billable and specific.
J70.2 is in Chapter 10 of the ICD-10-CM Tabular List.
Type 1 Excludes for J70.2 include: interstitial pneumonia NOS (J84.9); lymphoid interstitial pneumonia (J84.2).
Yes, J70.2 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.